Aalborg Boldspilklub A/S (CPH:AAB)
Denmark · Delayed Price · Currency is DKK 34.60
-2.00 (-5.46%)
Aug 7, 2025, 4:52 PM CET
Aerovate Therapeutics Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 75.19 | 81.83 | 85.16 | 64.28 | 43.64 | Upgrade |
Revenue Growth (YoY) | -8.12% | -3.90% | 32.48% | 47.27% | -27.71% | Upgrade |
Cost of Revenue | 16.55 | 16.96 | 16.46 | 19 | 16.56 | Upgrade |
Gross Profit | 58.64 | 64.87 | 68.7 | 45.28 | 27.09 | Upgrade |
Selling, General & Admin | 91.98 | 98.79 | 94.8 | 73.45 | 68.09 | Upgrade |
Other Operating Expenses | 9.2 | 15.49 | -16.97 | -9.47 | -34.47 | Upgrade |
Operating Expenses | 106.47 | 119.4 | 82.25 | 67.91 | 37.25 | Upgrade |
Operating Income | -47.83 | -54.53 | -13.56 | -22.63 | -10.17 | Upgrade |
Interest Expense | -1.63 | -1.25 | -0.8 | -0.62 | -0.63 | Upgrade |
Interest & Investment Income | 0.75 | 0.44 | 0.03 | 0.75 | 0.69 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | 22.16 | Upgrade |
EBT Excluding Unusual Items | -48.71 | -55.34 | -14.33 | -22.49 | 12.06 | Upgrade |
Gain (Loss) on Sale of Investments | 0.18 | 0.3 | -1.44 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 7.92 | 24.71 | - | - | - | Upgrade |
Asset Writedown | -3.56 | -4.08 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | 7.21 | - | Upgrade |
Pretax Income | -44.18 | -34.4 | -15.77 | -15.29 | 12.06 | Upgrade |
Income Tax Expense | - | - | - | - | 0.27 | Upgrade |
Earnings From Continuing Operations | -44.18 | -34.4 | -15.77 | -15.29 | 11.78 | Upgrade |
Net Income | -44.18 | -34.4 | -15.77 | -15.29 | 11.78 | Upgrade |
Net Income to Common | -44.18 | -34.4 | -15.77 | -15.29 | 11.78 | Upgrade |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | Upgrade |
Shares Change (YoY) | 52.06% | 49.00% | - | - | 191.45% | Upgrade |
EPS (Basic) | -20.23 | -23.95 | -16.36 | -15.86 | 12.23 | Upgrade |
EPS (Diluted) | -20.23 | -23.95 | -16.36 | -15.86 | 12.23 | Upgrade |
Free Cash Flow | -47.39 | -27.97 | -44.31 | 0.83 | 17.25 | Upgrade |
Free Cash Flow Per Share | -21.70 | -19.48 | -45.98 | 0.86 | 17.90 | Upgrade |
Gross Margin | 77.99% | 79.27% | 80.67% | 70.44% | 62.06% | Upgrade |
Operating Margin | -63.62% | -66.63% | -15.92% | -35.21% | -23.29% | Upgrade |
Profit Margin | -58.76% | -42.03% | -18.51% | -23.79% | 27.00% | Upgrade |
Free Cash Flow Margin | -63.03% | -34.17% | -52.04% | 1.29% | 39.53% | Upgrade |
EBITDA | -36.01 | -36.49 | 4.2 | -8.03 | 2.3 | Upgrade |
EBITDA Margin | -47.89% | -44.59% | 4.93% | -12.49% | 5.26% | Upgrade |
D&A For EBITDA | 11.83 | 18.04 | 17.75 | 14.6 | 12.46 | Upgrade |
EBIT | -47.83 | -54.53 | -13.56 | -22.63 | -10.17 | Upgrade |
EBIT Margin | -63.62% | -66.63% | -15.92% | -35.21% | -23.29% | Upgrade |
Effective Tax Rate | - | - | - | - | 2.26% | Upgrade |
Revenue as Reported | 75.19 | 81.83 | 85.16 | 71.48 | 65.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.